These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7637317)

  • 1. Genetic approaches to pathogenesis of neurodegenerative diseases.
    Orr HT; Clark HB
    Lab Invest; 1995 Aug; 73(2):161-71. PubMed ID: 7637317
    [No Abstract]   [Full Text] [Related]  

  • 2. Transgenic animals as models of neurodegenerative diseases in humans.
    Theuring F; Thunecke M; Kosciessa U; Turner JD
    Trends Biotechnol; 1997 Aug; 15(8):320-5. PubMed ID: 9263480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic zebrafish model of neurodegeneration.
    Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
    J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome instability and DNA repair in brain, ageing and neurological disease.
    Bohr VA; Ottersen OP; Tønjum T
    Neuroscience; 2007 Apr; 145(4):1183-6. PubMed ID: 17400394
    [No Abstract]   [Full Text] [Related]  

  • 5. Lesions and genes: on the edge of improved isomorphic models for Alzheimer's disease?
    Gonzalez de Aguilar JL; Loeffler JP; Boutillier AL
    Neurodegener Dis; 2008; 5(5):318-20. PubMed ID: 18520166
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation of the c-Jun transcription factor following neurodegeneration in vivo.
    Schenkel J
    Neurosci Lett; 2004 May; 361(1-3):36-9. PubMed ID: 15135887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent axonal degeneration in an Alzheimer mouse model.
    Wirths O; Weis J; Kayed R; Saido TC; Bayer TA
    Neurobiol Aging; 2007 Nov; 28(11):1689-99. PubMed ID: 16963164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scrg1 is induced in TSE and brain injuries, and associated with autophagy.
    Dron M; Bailly Y; Beringue V; Haeberlé AM; Griffond B; Risold PY; Tovey MG; Laude H; Dandoy-Dron F
    Eur J Neurosci; 2005 Jul; 22(1):133-46. PubMed ID: 16029203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp27 overexpression in the R6/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation.
    Zourlidou A; Gidalevitz T; Kristiansen M; Landles C; Woodman B; Wells DJ; Latchman DS; de Belleroche J; Tabrizi SJ; Morimoto RI; Bates GP
    Hum Mol Genet; 2007 May; 16(9):1078-90. PubMed ID: 17360721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q; Zhang X; Sun A
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical synthesis of polar zipper peptides: motifs for potential protein association in inherited neurodegenerative diseases.
    Johnson T
    Biomed Pept Proteins Nucleic Acids; 1995; 1(4):247-9. PubMed ID: 9346840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal replacement by intracerebral neural implants in animal models of neurodegenerative disease.
    Björklund A; Brundin P; Isacson O
    Adv Neurol; 1988; 47():455-92. PubMed ID: 3278526
    [No Abstract]   [Full Text] [Related]  

  • 13. Coexisting cholinergic and parahippocampal degeneration: a key to memory loss in dementia and a challenge for transgenic models?
    Cassel JC; Mathis C; Majchrzak M; Moreau PH; Dalrymple-Alford JC
    Neurodegener Dis; 2008; 5(5):304-17. PubMed ID: 18520165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation.
    Chen JF; Sonsalla PK; Pedata F; Melani A; Domenici MR; Popoli P; Geiger J; Lopes LV; de Mendonça A
    Prog Neurobiol; 2007 Dec; 83(5):310-31. PubMed ID: 18023959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the determinants of neurotropism and neurotoxicity of HFV in transgenic mice.
    Tschopp RR; Brandner S; Marino S; Bothe K; Horak I; Rethwilm A; Aguzzi A
    Virology; 1996 Feb; 216(2):338-46. PubMed ID: 8607263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia.
    Xia H; Mao Q; Eliason SL; Harper SQ; Martins IH; Orr HT; Paulson HL; Yang L; Kotin RM; Davidson BL
    Nat Med; 2004 Aug; 10(8):816-20. PubMed ID: 15235598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for evaluating the child with suspected neurodegenerative disease.
    Menkes JH
    Monatsschr Kinderheilkd; 1989 May; 137(5):254-6. PubMed ID: 2661995
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative proteomics in neurodegenerative and non-neurodegenerative diseases suggest nodal point proteins in regulatory networking.
    Zabel C; Sagi D; Kaindl AM; Steireif N; Kläre Y; Mao L; Peters H; Wacker MA; Kleene R; Klose J
    J Proteome Res; 2006 Aug; 5(8):1948-58. PubMed ID: 16889417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ORMOSIL nanoparticles as a non-viral gene delivery vector for modeling polyglutamine induced brain pathology.
    Klejbor I; Stachowiak EK; Bharali DJ; Roy I; Spodnik I; Morys J; Bergey EJ; Prasad PN; Stachowiak MK
    J Neurosci Methods; 2007 Sep; 165(2):230-43. PubMed ID: 17655935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
    Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
    Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.